Intuitive Surgical, Inc. $ISRG Shares Sold by Keybank National Association OH

Keybank National Association OH reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% during the second quarter, HoldingsChannel reports. The firm owned 91,577 shares of the medical equipment provider’s stock after selling 3,123 shares during the quarter. Keybank National Association OH’s holdings in Intuitive Surgical were worth $49,764,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Aaron Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 0.8% in the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after buying an additional 19 shares during the last quarter. FSM Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 3.8% in the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock worth $270,000 after buying an additional 20 shares during the last quarter. CFO4Life Group LLC increased its stake in shares of Intuitive Surgical by 4.8% in the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock worth $216,000 after buying an additional 20 shares during the last quarter. J. W. Coons Advisors LLC increased its stake in shares of Intuitive Surgical by 1.4% in the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after buying an additional 20 shares during the last quarter. Finally, Exencial Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 3.1% in the first quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock worth $327,000 after buying an additional 20 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. BTIG Research lifted their price target on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Daiwa Capital Markets boosted their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Leerink Partners boosted their target price on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. The Goldman Sachs Group boosted their target price on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Finally, Mizuho set a $575.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $537.59 on Thursday. The company has a 50-day simple moving average of $461.96 and a 200-day simple moving average of $498.01. The firm has a market capitalization of $192.72 billion, a P/E ratio of 71.11, a P/E/G ratio of 5.01 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.84 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 7,562 shares of the company’s stock in a transaction dated Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at approximately $193,595.79. This represents a 95.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the transaction, the chief executive officer owned 234,256 shares of the company’s stock, valued at $128,266,872.80. This represents a 9.47% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 96,011 shares of company stock valued at $50,309,042. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.